GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (BOM:500087) » Definitions » E10

Cipla (BOM:500087) E10 : ₹34.06 (As of Dec. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Cipla E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cipla's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹19.430. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹34.06 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Cipla's average E10 Growth Rate was 16.50% per year. During the past 3 years, the average E10 Growth Rate was -0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Cipla was -0.70% per year. The lowest was -10.90% per year. And the median was -5.80% per year.

As of today (2025-04-03), Cipla's current stock price is ₹1495.15. Cipla's E10 for the quarter that ended in Dec. 2024 was ₹34.06. Cipla's Shiller PE Ratio of today is 43.90.

During the past 13 years, the highest Shiller PE Ratio of Cipla was 53.47. The lowest was 10.28. And the median was 37.33.


Cipla E10 Historical Data

The historical data trend for Cipla's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipla E10 Chart

Cipla Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.53 30.55 25.01 26.55 29.88

Cipla Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.23 29.88 31.26 32.69 34.06

Competitive Comparison of Cipla's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Cipla's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipla's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipla's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cipla's Shiller PE Ratio falls into.


;
;

Cipla E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cipla's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=19.43/158.3229*158.3229
=19.430

Current CPI (Dec. 2024) = 158.3229.

Cipla Quarterly Data

per share eps CPI Adj_EPS
201503 3.220 97.163 5.247
201506 8.050 99.841 12.765
201509 6.740 101.753 10.487
201512 3.240 102.901 4.985
201603 -1.160 102.518 -1.791
201606 4.210 105.961 6.290
201609 4.400 105.961 6.574
201612 4.650 105.196 6.998
201703 -0.770 105.196 -1.159
201706 5.070 107.109 7.494
201709 5.240 109.021 7.610
201712 4.970 109.404 7.192
201803 2.220 109.786 3.201
201806 5.590 111.317 7.951
201809 4.670 115.142 6.421
201812 4.120 115.142 5.665
201903 4.550 118.202 6.094
201906 5.930 120.880 7.767
201909 5.840 123.175 7.506
201912 4.350 126.235 5.456
202003 3.040 124.705 3.860
202006 7.160 127.000 8.926
202009 8.240 130.118 10.026
202012 9.260 130.889 11.201
202103 5.120 131.771 6.152
202106 8.850 134.084 10.450
202109 8.800 135.847 10.256
202112 9.020 138.161 10.336
202203 4.490 138.822 5.121
202206 8.500 142.347 9.454
202209 9.770 144.661 10.693
202212 9.920 145.763 10.775
202303 6.510 146.865 7.018
202306 12.330 150.280 12.990
202309 14.000 151.492 14.631
202312 13.070 152.924 13.531
202403 11.620 153.035 12.022
202406 14.570 155.789 14.807
202409 16.120 157.882 16.165
202412 19.430 158.323 19.430

Add all the adjusted EPS together and divide 10 will get our e10.


Cipla  (BOM:500087) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cipla's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1495.15/34.06
=43.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Cipla was 53.47. The lowest was 10.28. And the median was 37.33.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cipla E10 Related Terms

Thank you for viewing the detailed overview of Cipla's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipla Business Description

Traded in Other Exchanges
Address
Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.

Cipla Headlines

No Headlines